Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities

被引:20
作者
Luo, W [1 ]
Hsu, JCF [1 ]
Tsao, CY [1 ]
Ko, E [1 ]
Wang, XH [1 ]
Ferrone, S [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
D O I
10.4049/jimmunol.174.11.7104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptide mimics isolated from phage display peptide libraries by panning with self-tumor-associated Ag (TAA)-specific mAbs are being evaluated as immunogens to implement active specific immunotherapy. Although TAA-specific mAb are commonly used to isolate peptide mimics, no information is available regarding the Ab characteristics required to isolate immunogenic TAA peptide mimics. To address this question, we have used mAb 763.74 and mAb GH786, which recognize the same or spatially close antigenic determinant(s) of the human high m.w.-melanoma-associated Ag (HMW-MAA), although with different affinity. mAb 763.74 affinity is higher than that of mAb GH786. Panning of phage display peptide libraries with mAb 763.74 and mAb GH786 resulted in the isolation of peptides P763.74 and PGH786, respectively. When compared for their ability to induce HMW-MAA-specific immune responses in BALB/c mice, HMW-MAA-specific Ab titers were significantly higher in mice immunized with P763.74 than in those immunized with PGH786. The HMW-MAA-specific Ab titers were markedly increased by a booster with HMW-MAA-bearing melanoma cells, an effect that was significantly higher in mice primed with P763.74 than in those primed with PGH786. Lastly, P763.74, but not PGH786, induced a delayed-type hypersensitivity response to HMW-MAA-bearing melanoma cells. These findings suggest that affinity for TAA is a variable to take into account when selecting mAb to isolate peptide mimics from a phage display peptide library.
引用
收藏
页码:7104 / 7110
页数:7
相关论文
共 40 条
[1]   Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage [J].
Bonnycastle, LLC ;
Mehroke, JS ;
Rashed, M ;
Gong, X ;
Scott, JK .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 258 (05) :747-762
[2]   Tumor antigens recognized by T cells [J].
Boon, T ;
Coulie, PG ;
VandenEynde, B .
IMMUNOLOGY TODAY, 1997, 18 (06) :267-268
[3]   Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside [J].
Chapman, PB ;
Wu, D ;
Ragupathi, G ;
Lu, S ;
Williams, L ;
Hwu, WJ ;
Johnson, D ;
Livingston, PO .
CLINICAL CANCER RESEARCH, 2004, 10 (14) :4717-4723
[4]  
CHAPMAN PB, 1994, VACCINE RES, V3, P59
[5]  
CHEN ZJ, 1991, J IMMUNOL, V147, P1082
[6]  
CHEN ZJ, 1993, CANCER RES, V53, P112
[7]  
Cunto-Amesty G, 2003, CELL MOL BIOL, V49, P245
[8]   Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on β2-microglobulin-associated and β2-microglobulin-free HLA class I heavy chains [J].
Desai, SA ;
Wang, XH ;
Noronha, EJ ;
Zhou, QW ;
Rebmann, V ;
Grosse-Wilde, H ;
Moy, FJ ;
Powers, R ;
Ferrone, S .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3275-3283
[9]   IMMUNE-RESPONSE TO THE CARCINOEMBRYONIC ANTIGEN IN PATIENTS TREATED WITH AN ANTIIDIOTYPE ANTIBODY VACCINE [J].
FOON, KA ;
CHAKRABORTY, M ;
JOHN, WJ ;
SHERRATT, A ;
KOHLER, H ;
BHATTACHARYACHATTERJEE, M .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :334-342
[10]   Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen [J].
Föster-Waldl, E ;
Riemer, AB ;
Dehof, AK ;
Neumann, D ;
Brämswig, K ;
Boltz-Nitulescu, G ;
Pehamberger, H ;
Zielinski, CC ;
Scheiner, O ;
Pollak, A ;
Lode, H ;
Jensen-Jarolim, E .
MOLECULAR IMMUNOLOGY, 2005, 42 (03) :319-325